Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt repayments
Ratios

Bio-Techne (TECH) Shares Outstanding (2016 - 2026)

Bio-Techne has reported Shares Outstanding over the past 17 years, most recently at $155.9 million for Q4 2025.

  • For Q4 2025, Shares Outstanding fell 1.29% year-over-year to $155.9 million; the TTM value through Dec 2025 reached $155.9 million, down 1.29%, while the annual FY2025 figure was $155.0 million, 2.05% down from the prior year.
  • Shares Outstanding for Q4 2025 was $155.9 million at Bio-Techne, roughly flat from $155.7 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $158.9 million in Q3 2024 and troughed at $38.9 million in Q1 2021.
  • A 5-year average of $151.2 million and a median of $157.1 million in 2021 define the central range for Shares Outstanding.
  • Biggest five-year swings in Shares Outstanding: soared 305.72% in 2021 and later decreased 2.05% in 2025.
  • Year by year, Shares Outstanding stood at $157.3 million in 2021, then decreased by 0.12% to $157.1 million in 2022, then increased by 0.03% to $157.1 million in 2023, then increased by 0.49% to $157.9 million in 2024, then decreased by 1.29% to $155.9 million in 2025.
  • Business Quant data shows Shares Outstanding for TECH at $155.9 million in Q4 2025, $155.7 million in Q3 2025, and $155.0 million in Q2 2025.